The Anteotech (ASX:ADO) share price is surging. Here’s why.

The AnteoTech Ltd (ASX: ADO) share price has rocketed higher this morning after receiving key approvals in Europe and the UK.

| More on:
covid vaccine shares represented by numbers 2021 with the one displayed as syringe

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Anteotech Ltd (ASX: ADO) share price surged 8% higher at the open after a key update on European regulation for its rapid COVID-19 test.

At the time of writing, the AnteoTech share price is trading at 27 cents, up 6%.

Why is the AnteoTech share price surging?

AnteoTech announced that it had received Conformite Europeenne (CE) Mark registration for its EuGeni Reader and in vitro rapid diagnostic test, COVID-19 Antigen Rapid Test (ART).

The EuGeni COVID-19 ART is a single-use rapid test for health professionals to test for suspected COVID-19 infection. The proprietary test has an overall sensitivity of 97.3% and specificity of 99.6%, according to AnteoTech.

The CE Mark registration means the EuGeni Reader and the COVID-19 ART conform with health and safety standards for the European Economic Area (EE) and the United Kingdom. It’s an important step forward for the Queensland-based Aussie biotech company.

That’s been reflected in the AnteoTech share price surge we’ve seen this morning. Thanks to the CE Mark registration news, shares in the biotech company have rocketed 8% higher at the open.

What it means

With the latest approvals, AnteoTech can now sell its EuGeni Reader and COVID-19 ART. The company hopes to “deliver a high performing and high sensitivity test”.

AnteoTech CEO Derek Thomson said the company was “delighted to have achieved this significant milestone in our strategy to become a legal manufacturer of rapid tests”. There are also other strategic plans in the works. AnteoTech hopes to support sales with a “saliva use case and new COVID-19/Flu A/Flu B Multiplex test”.

The AnteoTech share price has continued to search higher amid the pandemic. Before Monday’s open, shares in the Aussie biotech had surged 1,228.9% higher to $0.25 per share. That includes a 31.6% surge in the last month amid strong testing results for its proprietary detection tests.

Foolish takeaway

The AnteoTech share price has been surging higher to start the year. This morning is no exception on the back of receiving approvals for its EuGeni COVID-19 ART for sale in Europe and the United Kingdom.

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A graph ablaze with fire going up, indicating a fired up and surged share price
Share Gainers

These 3 ASX 200 tech shares are on fire today

Tech shares are broadly outperforming today following a strong lead from the US NASDAQ.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Share Gainers

Why Regis Resources, Sayona, Woodside, and Xero shares are pushing higher

These ASX shares are on form on Tuesday...

Read more »

A GWR Group female employee in a hard hat and overalls with high visibility stripes sits at the wheel of a large mining vehicle with mining equipment in the background.
Resources Shares

Why has the Pilbara Minerals share price soared 57% in FY22?

How did the Pilbara Minerals share price perform in the financial year?

Read more »

A man with a scrappy beard and wearing dark sunglasses and a beanie head covering raises a fist in happy celebration as he sits at is computer in a home environment.
Technology Shares

How Brainchip shares gained 63% in a year when tech stocks nosedived

The computer hardware provider was once considered a meme stock. Is it fair dinkum now?

Read more »

A technical manufacturer checks his work in a high-tech lab with precision equipment in the background.
Share Gainers

Guess which ASX All Ords share soared 21% to an 8-year high on Monday

One ASX All Ordinaries share enjoyed a stellar start to the week.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Share Gainers

Why APM, Block, Breville, and Superloop shares are charging higher

These ASX shares are charging higher on Monday...

Read more »

health workers shake hands and congratulate each other on good news
Share Gainers

This ASX All Ordindaries healthcare share is ripping 17% higher amid a new contract win

Investors seem to like the contract win from this healthcare player.

Read more »

A boy leaps and flaps his arms as he tries to fly with some birds on the shoreline of the beach.
Share Gainers

5 best ASX All Ordinaries shares in June

Why did these ASX shares fly while the All Ords dropped?

Read more »